Search for other papers by Weiwei He in
Google Scholar
PubMed
Search for other papers by Bin Wang in
Google Scholar
PubMed
Search for other papers by Kaida Mu in
Google Scholar
PubMed
Search for other papers by Jing Zhang in
Google Scholar
PubMed
Search for other papers by Yanping Yang in
Google Scholar
PubMed
Search for other papers by Wei Yao in
Google Scholar
PubMed
Search for other papers by Sheli Li in
Google Scholar
PubMed
Search for other papers by Jin-an Zhang in
Google Scholar
PubMed
occurs in generations of the same family has been identified in HT. GD is one of the most common causes of hyperthyroidism characterized by positive thyroid-stimulating hormone (TSH) receptor antibodies (TRAb) and is an organ-specific autoimmune disease
Search for other papers by Ru-Xuan Zhao in
Google Scholar
PubMed
Search for other papers by Ting-Ting Shi in
Google Scholar
PubMed
Search for other papers by Sha Luo in
Google Scholar
PubMed
Search for other papers by Yun-Fu Liu in
Google Scholar
PubMed
Search for other papers by Zhong Xin in
Google Scholar
PubMed
Search for other papers by Jin-Kui Yang in
Google Scholar
PubMed
group, 24 patients were considered to be hyperthyroid and another 24 to be euthyroid at the time of assessment, and only patients in the former category were treated with antithyroid drugs. Thyroid function in the control group matched that in the active
Search for other papers by Xiaowen Zhang in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, Drum Tower Clinical Medical College, Southeast University, Nanjing, China
Search for other papers by Chen Han in
Google Scholar
PubMed
Search for other papers by Hongwei Wang in
Google Scholar
PubMed
Search for other papers by Xinghong Sun in
Google Scholar
PubMed
Search for other papers by Xin Dou in
Google Scholar
PubMed
Search for other papers by Xueying He in
Google Scholar
PubMed
Search for other papers by Di Wu in
Google Scholar
PubMed
Search for other papers by Shanmei Shen in
Google Scholar
PubMed
Search for other papers by Dalong Zhu in
Google Scholar
PubMed
Search for other papers by Xinlin Zhang in
Google Scholar
PubMed
Search for other papers by Yan Bi in
Google Scholar
PubMed
January 2018 to October 2021. GD was diagnosed based on hyperthyroidism associated with anti-thyrotrophic hormone (TSH) receptor autoantibodies (TRAb). TED was diagnosed by the ophthalmology department based on clinical ophthalmic examinations. TED
Search for other papers by Zhengrong Jiang in
Google Scholar
PubMed
Search for other papers by Linghong Huang in
Google Scholar
PubMed
Search for other papers by Lijun Chen in
Google Scholar
PubMed
Search for other papers by Jingxiong Zhou in
Google Scholar
PubMed
Search for other papers by Bo Liang in
Google Scholar
PubMed
Search for other papers by Xuefeng Bai in
Google Scholar
PubMed
Search for other papers by Lizhen Wu in
Google Scholar
PubMed
Search for other papers by Huibin Huang in
Google Scholar
PubMed
Introduction Graves’ disease (GD) is an organ-specific autoimmune disease that commonly manifests as hyperthyroidism and diffuse goitre. The annual incidence of GD is 20–50 cases per 100,000 people worldwide ( 1 , 2 ). The GD phenotype is
Search for other papers by Xi Cao in
Google Scholar
PubMed
Search for other papers by Ming Lu in
Google Scholar
PubMed
Search for other papers by Rong-Rong Xie in
Google Scholar
PubMed
Search for other papers by Li-Ni Song in
Google Scholar
PubMed
Search for other papers by Wei-Li Yang in
Google Scholar
PubMed
Search for other papers by Zhong Xin in
Google Scholar
PubMed
Search for other papers by Guang-Ran Yang in
Google Scholar
PubMed
Search for other papers by Jin-Kui Yang in
Google Scholar
PubMed
were excluded. According to FT4 and TSH concentrations, six subjects with clinical hyperthyroidism and six subjects with clinical hypothyroidism were later excluded. Finally, 1103 euthyroid and 92 SCH subjects were assessed. This study was approved by
Princess Máxima Center for Pediatric Oncology, AB Utrecht, The Netherlands
Search for other papers by Ichelle Maa van Roessel in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, AB Utrecht, The Netherlands
Search for other papers by Boudewijn Bakker in
Google Scholar
PubMed
Princess Máxima Center for Pediatric Oncology, AB Utrecht, The Netherlands
Search for other papers by Hanneke M van Santen in
Google Scholar
PubMed
Search for other papers by Wassim Chemaitilly in
Google Scholar
PubMed
or prognostic factor in childhood cancer. In non-CCS adults, hyperthyroidism has been associated with increased cancer risk, especially lung, prostate, breast, ovarian and thyroid cancer ( 36 , 38 ). Correlations have also been reported between serum
Diabetes and Endocrine Unit, National Hospital, Kandy, Sri Lanka
Search for other papers by G Amiyangoda in
Google Scholar
PubMed
Search for other papers by C N Antonypillai in
Google Scholar
PubMed
Search for other papers by S S C Gunatilake in
Google Scholar
PubMed
Search for other papers by T T Weerathunge in
Google Scholar
PubMed
Search for other papers by D Ediriweera in
Google Scholar
PubMed
Search for other papers by S G P D Kosgallana in
Google Scholar
PubMed
Search for other papers by R D P Jayawardana in
Google Scholar
PubMed
Search for other papers by H A N D Thissera in
Google Scholar
PubMed
Search for other papers by W J Emalka in
Google Scholar
PubMed
Search for other papers by H U Daraniyagala in
Google Scholar
PubMed
FT4 values between cases and controls at all time intervals (0, 60, 120, 180, 240, and 300 min) as shown in plot (B) of Fig. 2 and Table 2 . No adverse events or symptoms of hyperthyroidism were reported, and heart rate and blood pressure
Search for other papers by Aasem Saif in
Google Scholar
PubMed
Search for other papers by Shrook Mousa in
Google Scholar
PubMed
Search for other papers by Maha Assem in
Google Scholar
PubMed
Search for other papers by Nashwa Tharwat in
Google Scholar
PubMed
Vascular Laboratory, Cairo University, Cairo, Egypt
Search for other papers by Alaa Abdelhamid in
Google Scholar
PubMed
. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes
Search for other papers by Keina Nishio in
Google Scholar
PubMed
Search for other papers by Akiko Tanabe in
Google Scholar
PubMed
Search for other papers by Risa Maruoka in
Google Scholar
PubMed
Search for other papers by Kiyoko Nakamura in
Google Scholar
PubMed
Search for other papers by Masaaki Takai in
Google Scholar
PubMed
Search for other papers by Tatsuharu Sekijima in
Google Scholar
PubMed
Search for other papers by Satoshi Tunetoh in
Google Scholar
PubMed
Search for other papers by Yoshito Terai in
Google Scholar
PubMed
Search for other papers by Masahide Ohmichi in
Google Scholar
PubMed
to the established protocols from January 2006 to December 2008. Women with a current or past medical condition or medication use that may influence bone mineral metabolism (hyperthyroidism, rheumatoid arthritis, history of fractures that can be
Endocrine Disease Unit, University-Hospital of Padova, Padova, Italy
Department of Neuroscience DNS, University of Padova, Padova, Italy
Search for other papers by Filippo Ceccato in
Google Scholar
PubMed
Search for other papers by Elisa Selmin in
Google Scholar
PubMed
Laboratory Medicine, University-Hospital of Padova, Padova, Italy
Search for other papers by Giorgia Antonelli in
Google Scholar
PubMed
Endocrine Disease Unit, University-Hospital of Padova, Padova, Italy
Department of Neuroscience DNS, University of Padova, Padova, Italy
Search for other papers by Mattia Barbot in
Google Scholar
PubMed
Search for other papers by Andrea Daniele in
Google Scholar
PubMed
Search for other papers by Marco Boscaro in
Google Scholar
PubMed
Laboratory Medicine, University-Hospital of Padova, Padova, Italy
Search for other papers by Mario Plebani in
Google Scholar
PubMed
Endocrine Disease Unit, University-Hospital of Padova, Padova, Italy
Search for other papers by Carla Scaroni in
Google Scholar
PubMed
encountered in clinical practice, like subclinical hypercortisolism, hypo- or hyperthyroidism, and so on ( 26 , 27 , 28 ). Two meta-analyses ( 4 , 7 ) previously showed and the Endocrine Society guidelines ( 2 ) have reiterated that corticotropin test